These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22587514)

  • 1. Glucagon and cyclic AMP: time to turn the page?
    Rodgers RL
    Curr Diabetes Rev; 2012 Sep; 8(5):362-81. PubMed ID: 22587514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.
    Rodgers RL
    Physiol Rep; 2022 May; 10(9):e15263. PubMed ID: 35569125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reappraisal of the role of cyclic AMP in the physiological action of glucagon.
    Rodgers RL
    Peptides; 2023 Jan; 159():170906. PubMed ID: 36396082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like stimulation of cardiac fuel metabolism by physiological levels of glucagon: involvement of PI3K but not cAMP.
    Harney JA; Rodgers RL
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E155-61. PubMed ID: 18492769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal control of pyruvate kinase activity and of gluconeogenesis in isolated hepatocytes.
    Feliú JE; Hue L; Hers HG
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2762-6. PubMed ID: 183209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
    Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
    Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute glucagon induces postprandial peripheral insulin resistance.
    Patarrão RS; Lautt WW; Macedo MP
    PLoS One; 2015; 10(5):e0127221. PubMed ID: 25961284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced sensitivity of the hepatic adenylate cyclase-cyclic AMP system to glucagon during sustained hormonal stimulation.
    DeRubertis FR; Craven P
    J Clin Invest; 1976 Feb; 57(2):435-43. PubMed ID: 176180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy.
    Yang H; Yang L
    J Mol Endocrinol; 2016 Aug; 57(2):R93-R108. PubMed ID: 27194812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin: interaction with membrane receprots and relationship to cyclic purine nucleotides and cell growth.
    Hollenberg MD; Cuatrecasas P
    Fed Proc; 1975 Jun; 34(7):1556-63. PubMed ID: 165982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rapid changes of hepatic glycolytic enzymes and fructose-1,6-diphosphatase activities after intravenous glucagon in humans.
    Greene HL; Taunton OD; Stifel FB; Herman RH
    J Clin Invest; 1974 Jan; 53(1):44-51. PubMed ID: 4357616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.
    Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
    J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglucagonemia and altered responsiveness of hepatic adenylate cyclase-adenosine 3',5'-monophosphate system to hormonal stimulation during chronic ingestion of DL-ethionine.
    Craven PA; Derubertis FR
    Biochim Biophys Acta; 1977 Apr; 497(2):415-27. PubMed ID: 192313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of lipogenic enzyme and phosphoenolpyruvate carboxykinase gene expression in cultured white adipose tissue. Glucose and insulin effects are antagonized by cAMP.
    Foufelle F; Gouhot B; Perdereau D; Girard J; Ferre P
    Eur J Biochem; 1994 Aug; 223(3):893-900. PubMed ID: 7914489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
    Bergman RN
    Recent Prog Horm Res; 1997; 52():359-85; discussion 385-7. PubMed ID: 9238859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased glucagon-stimulated cyclic AMP production by isolated liver cells of rats with type 2 diabetes.
    Portha B; Chamras H; Broer Y; Picon L; Rosselin G
    Mol Cell Endocrinol; 1983 Sep; 32(1):13-26. PubMed ID: 6313452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of insulin-glucagon interactions on glycogenolysis and protein kinase activity in rat hepatocytes.
    Hayes JS; Byus CV; Russell DH; Brendel K
    Life Sci; 1982 Nov; 31(22):2519-27. PubMed ID: 6296582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon revisited: Coordinated actions on the liver and kidney.
    Bankir L; Bouby N; Speth RC; Velho G; Crambert G
    Diabetes Res Clin Pract; 2018 Dec; 146():119-129. PubMed ID: 30339786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation by glucagon (cAMP) and insulin of the promoter of the human phosphoenolpyruvate carboxykinase gene (cytosolic) in cultured rat hepatocytes and in human hepatoblastoma cells.
    Rucktäschel AK; Granner DK; Christ B
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):211-7. PubMed ID: 11062075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glucagon-signaling and downstream actions by interleukin 1beta and tumor necrosis factor alpha in cultured primary rat hepatocytes.
    Christ B
    Horm Metab Res; 2008 Jan; 40(1):18-23. PubMed ID: 18335579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.